February 6, 2023
Personalized drug discovery at lightspeed
HiFiBiO Therapeutics and CSEM are collaborating to develop and manufacture single-cell microfluidics that will enable novel immunotherapies for the treatment of cancer and autoimmune diseases. A new paradigm is emerging thanks to the integration of deep biological expertise and data intelligence.
© CSEM - Photograph of the microfluidic chip. The inlets and outlets can be seen, as well as the two gold electrodes that cause the cells to be sorted.
Related News
1 December 2025
A biodegradable smart sensor to monitor sensitive goods
GREENsPACK is a sustainable smart sensing tag that can be used to signal when shipments of medicines or food have exceeded a safe threshold temperature. The tag was presented in the scientific journal...
9 July 2024
Microfabricated chip for X-ray medical images technology
Nanotechnology is fundamentally changing medical imaging. At the heart of the new X-ray CT scanner Nanox.ARC: A MEMS chip consisting of millions of homogeneous nanocones produced by the specialized ME...
23 November 2022
CSEM and ECAL create art using advanced technology
Students from the Lausanne University of Art and Design (ECAL) have teamed up with CSEM’s engineers to create an avant-garde iridescent jewelry collection. ...